Cost Effectiveness of a CYP2C19 Genotype-Guided Strategy in Patients with Acute Myocardial Infarction: Results from the POPular Genetics Trial.

Daniël M F ClaassensPim W M van DorstGerrit J A VosThomas O BergmeijerRenicus S HermanidesArnoud W J van 't HofPim van der HarstEmanuele BarbatoCarmine MoriscoRichard M Tjon Joe GinFolkert W AsselbergsArend MosterdJean-Paul R HerrmanWillem J M DewildeMaarten J PostmaVera H M DeneerJurriën M Ten BergCornelis Boersma

Published in: American journal of cardiovascular drugs : drugs, devices, and other interventions (2021)

Clinicaltrials.gov number: NCT01761786, Netherlands trial register number: NL2872.

Keyphrases

acute myocardial infarction
phase iii
study protocol
phase ii
clinical trial
percutaneous coronary intervention
randomized controlled trial
open label
heart failure
coronary artery disease
atrial fibrillation